Cargando…
Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach
BACKGROUND: Mesenchymal stromal cells (MSCs), commonly sourced from adipose tissue, bone marrow and umbilical cord, have been widely used in many medical conditions due to their therapeutic potential. Yet, the still limited understanding of the underlying mechanisms of action hampers clinical transl...
Autores principales: | Calcat-i-Cervera, Sandra, Rendra, Erika, Scaccia, Eleonora, Amadeo, Francesco, Hanson, Vivien, Wilm, Bettina, Murray, Patricia, O’Brien, Timothy, Taylor, Arthur, Bieback, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161493/ https://www.ncbi.nlm.nih.gov/pubmed/37143116 http://dx.doi.org/10.1186/s13287-023-03352-1 |
Ejemplares similares
-
Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality
por: Skovronova, Renata, et al.
Publicado: (2023) -
Recent advances in understanding mesenchymal stromal cells
por: Rendra, Erika, et al.
Publicado: (2020) -
When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease
por: Calcat-i-Cervera, Sandra, et al.
Publicado: (2021) -
Multicentre quantitative (68)Ga PET/CT performance harmonisation
por: Huizing, Daphne M. V., et al.
Publicado: (2019) -
Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies
por: Amadeo, Francesco, et al.
Publicado: (2021)